<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport Launches New Logistics Service Supporting Facility Relocation of Cryogenically Frozen Sample Collections

February 17, 2015

Lake Forest, CA, February 17, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the launch of a new logistics service supporting complete facility relocation of critical cryogenically frozen sample collections.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Lab, Clinic, Relocation

Cryoport Initiates Support of the Growing In-Vitro Fertilization Market in Nepal

February 10, 2015

Lake Forest, CA, February 10, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it has initiated support of the growing in-vitro fertilization (“IVF”) market in Nepal.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, frozen shipping solution, Cold Chain Logistics, IVF, Nepal

Cryoport Designated as Exclusive Cryogenic Logistics Provider to Triangle Research Labs

December 29, 2014

Lake Forest, CA, December 29, 2014 - Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for life sciences, announced today that it has entered into an agreement with Triangle Research Labs, LLC (“TRL”).  Under the agreement, Cryoport becomes the exclusive cryogenic logistics provider for TRL, providing it with the ability to support its overall demand growth and meet its ever-increasing demand for same day cryogenic shipping.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Triangle Research Labs, hepatocyte

Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry

November 3, 2014

Lake Forest, CA, November 3, 2014 - Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, Frozen Shipping, frozen shipping solution, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, UPS

Cryoport to Present at LD Micro Growth Conference on December 3, 2013

November 15, 2013

LAKE FOREST, CA – November 15, 2013 — Cryoport, Inc. (OTCBB: CYRX) today announced that Chief Executive Officer Jerrell Shelton and Chief Financial Officer Robert Stefanovich are scheduled to present to investors at the 6th Annual LD Micro Growth Conference on Tuesday, December 3, 2013 at 3:00 PM PST. 

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, LD Micro Growth Conference, frozen shipping solution

Impact of Government Shut Down on Shipping

October 2, 2013

Dear Clients,

Read More


Tags: frozen shipping solution, Government Shut Down, 24/7 Support

Cryoport and Ocasa Align for Global Cold Chain

September 26, 2013

LAKE FOREST, CA – September 26, 2013 — Cryoport, Inc. (OTCBB: CYRX) and OCASA, Inc. have entered into a master services agreement to provide global cold chain logistics solutions for life science and biotech commodities requiring cryogenic temperatures. OCASA will have access to Cryoport’s full range of cryogenic business solution capabilities including its proprietary Cryoport Express® Shippers and cloud-based logistics management software platform, the CryoportalTM. Cryoport will leverage OCASA’s global logistics network to provide more complete global services to its customers. In conjunction with Cryoport and OCASA providing each other with logistics solutions, the Companies will engage in co-marketing, joint sales activities, and a wide range of customer-driven support requirements to provide comprehensive and seamless solutions to the life sciences and biotech industries.

Read More


Tags: Dry Shipper, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Zoetis, Pfizer, frozen shipping solution, Vaccines, Animal HealthDry Shipper, OCASA